Quarter Financials
Alexion Pharmaceuticals, Inc. (ALXN)
$182.5
0.00 (0.00%)
Income Statement
Balance Sheet
Cash Flow
|
Year
|
2021 Q1
|
2020 Q4
|
2020 Q3
|
2020 Q2
|
2020 Q1
|
2019 Q4
|
2019 Q3
|
2019 Q2
|
|---|
| Net Income | 636 | 536 | 578 | -1,068 | 558 | 889 | 468 | 460 |
|---|
| Dividend Paid | - | - | - | - | - | - | - | - |
|---|
| Retained Earnings | 5,879 | 5,243 | 4,707 | 4,129 | 5,197 | 4,640 | 3,751 | 3,283 |
|---|
|
Year
|
2021 Q1
|
2020 Q4
|
2020 Q3
|
2020 Q2
|
2020 Q1
|
2019 Q4
|
2019 Q3
|
2019 Q2
|
|---|
| Capital Expenditure | -130 | -78 | -29 | -6 | -12 | -30 | -50 | -47 |
|---|
| Net PPE | 1,462 | 1,462 | 1,214 | 1,196 | 1,159 | 1,163 | 1,148 | 1,123 |
|---|
|
Year
|
2021 Q1
|
2020 Q4
|
2020 Q3
|
2020 Q2
|
2020 Q1
|
2019 Q4
|
2019 Q3
|
2019 Q2
|
|---|
| New Purchases | -46 | -33 | -43 | -61 | -6 | -5 | -6 | -7 |
|---|
| Intangible and Goodwill | 5,037 | 5,037 | 5,037 | 5,072 | 5,075 | 5,101 | 5,100 | 5,100 |
|---|